SmileDirectClub, IPO: What to Know Before It Lists
SmileDirectClub, Inc. is expected to list on NASDAQ on 2026-11-18, but the price range has not been disclosed. The company is a direct-to-consumer oral care and medtech platform built around teledentistry and clear aligners. Watch for how investors weigh fast revenue growth against regulatory risk, litigation, and leverage.
SmileDirectClub, Inc. is expected to list on NASDAQ on 2026-11-18, but the price range has not been disclosed. The company is a direct-to-consumer oral care and medtech platform built around teledentistry and clear aligners. Watch for how investors weigh fast revenue growth against regulatory risk, litigation, and leverage.
Quick Facts
Expected listing date: November 18, 2026
Exchange: NASDAQ
Proposed symbol: SDC
Status: Expected
Company Overview
SmileDirectClub described itself in its SEC filings as an oral care and medtech company and the first direct-to-consumer medtech platform for transforming smiles. Its model combined teledentistry with a vertically integrated system for clear aligner therapy and related oral care products. Revenue came primarily from aligners, impression kits, whitening gel, and retainers, and the company also operated as a dental support organization providing non-clinical administrative support services to a network of doctors.
The company was founded in 2014 and is headquartered in Nashville, Tennessee. Its pitch sits in a large orthodontics and oral care market where consumers are increasingly drawn to lower-cost, more convenient alternatives to traditional treatment. The broader industry backdrop includes e-commerce adoption, remote care, and digital workflows, but also intense scrutiny from state dental boards and ongoing debate over how far teledentistry can go in orthodontic care. That makes SmileDirectClub a consumer-health story as much as a healthcare-distribution story.
Why They're Going Public
In its S-1, SmileDirectClub said it intended to use all net proceeds from the offering to purchase newly issued limited liability company units from SDC Financial LLC, its operating subsidiary. SDC Financial would then use part of those proceeds to buy LLC units from existing holders. Reuters summarized the proceeds as going toward redeeming LLC units from pre-IPO investors, funding a dividend to them, and paying bonuses and related tax obligations.
That structure means the IPO was not mainly about funding a new operating buildout; it was also a liquidity event for existing owners and a way to simplify the capital structure around the operating business. For public shareholders, the key question is whether the listing helps the company gain broader market visibility and access to capital while it continues to scale a controversial but fast-growing consumer healthcare model.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
SmileDirectClub showed very rapid top-line growth ahead of its IPO. The company reported 2018 revenue of $423.234 million, up from $145.954 million in 2017, which implies growth of about 190%. In the first half of 2019, revenue reached $373.530 million versus $175.064 million in the first half of 2018, implying growth of about 113%. That is the kind of growth profile that drew attention in the 2019 IPO market.
Profitability was improving at the gross level, but net losses were still significant. The company reported 2018 gross profit of $289.266 million and a gross margin of about 68%, versus about 56% in 2017. Reuters reported a 2018 net loss of $74.8 million, wider than the $32.8 million loss in 2017, and a first-half 2019 net loss of $52.9 million. The filing also showed meaningful leverage, including $171.478 million of long-term debt net of current portion at June 30, 2019. The retrieved filing excerpts do not show a clean cash balance line, so the exact cash position is not visible here.
Risk Factors
The biggest risk is regulatory. SmileDirectClub disclosed that state dental boards had adopted rules or interpretations that could limit or restrict the business, and that legal and regulatory scrutiny could affect how it operates. That matters because the company’s model depends on remote workflows and a structure that sits between consumer retail and clinical dental care.
Litigation is another major overhang. The company disclosed multiple securities and consumer lawsuits tied to the IPO and advertising claims. It also faces operating risks from dependence on freight carriers and exposure to higher freight and fuel costs, which could pressure gross margin. Data privacy and security risks are also material, including HIPAA, state privacy laws, GDPR, and PIPEDA exposure. On top of that, the company’s profitability path is still not proven, and the IPO structure and lockup create the usual risk of selling pressure once early holders are free to exit.
Comparable Public Companies
The closest public comps are Align Technology (ALGN), Envista Holdings (NVST), Henry Schein (HSIC), Dentsply Sirona (XRAY), and Straumann Holding (STMN). Align is the most direct strategic comparator because it competes in clear aligners, while the others give a broader read on dental equipment, supplies, and orthodontic demand. SmileDirectClub’s model is more consumer-facing and more controversial than most of these peers, which is why the market has tended to assign it a different risk profile.
Relative to those comps, SmileDirectClub came to market with much faster revenue growth but also much heavier regulatory and litigation risk. The retrieved materials do not provide current valuation multiples or recent stock performance for the peer set, so a precise trading comparison is not available here. Broadly, this is a mixed sector rather than a uniformly hot one: the market has rewarded growth and digital healthcare themes at times, but it has also been selective with unprofitable consumer-health names, especially when the business model invites legal scrutiny.
Verdict
The setup favors a watchful read on pricing, not a simple growth story. If this were pricing today, shareholders should watch how the company is valued against its 2018 revenue of $423.234 million, its 68% gross margin, and the fact that it still posted a $74.8 million net loss in 2018 and carried $171.478 million of long-term debt at mid-2019. The key question is whether investors are willing to pay up for the growth rate while accepting the regulatory and litigation overhang.
The market-timing angle matters because this is the kind of IPO that tests appetite for controversial consumer-health disruptors. The broader IPO window in 2019 was open but selective, and SmileDirectClub’s weak first-day trading history showed that large, high-profile deals were not getting a free pass. What makes the story noteworthy is the intersection of teledentistry, direct-to-consumer healthcare, and regulatory pushback. That combination can create a powerful narrative, but it also makes execution and compliance central to how the stock is received.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.